US Patent 11850229 Treatment of circadian rhythm disorders
Patent 11850229 was granted and assigned to Vanda Pharmaceuticals on December, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11850229 Treatment of circadian rhythm disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
